Search results for "PLGA"

showing 10 items of 31 documents

PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.

2018

The oral controlled release (CR) formulations have become more important in recent years. Among them, the polymeric nanoparticles have been thoroughly studied during the last decades, consequently they are extensively employed for a broad range of applications and drugs. The objective of this research was to develop polymeric nanoparticles (NPs) of ibuprofen with poly(lactic-co-glycolic) acid (PLGA) as polymer, and to test their applicability for oral CR formulations development. Different proportions of drug/polymer were employed to develop the ibuprofen NPs and their in vitro release profiles were analysed. The in situ segmental permeability of ibuprofen was tested in Wistar rat and demon…

DrugMaleColonPolymersmedia_common.quotation_subjectPharmaceutical ScienceIbuprofen02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivomedicineAnimalsLactic AcidRats Wistarmedia_commonchemistry.chemical_classificationDrug CarriersChromatographyorganic chemicalstechnology industry and agriculturePolymer021001 nanoscience & nanotechnologyIbuprofenControlled releaseRatsPLGAchemistryIntestinal AbsorptionPermeability (electromagnetism)Delayed-Action PreparationsNanoparticles0210 nano-technologyPolyglycolic Acidmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Antibacterial drug release from a biphasic gel system: Mathematical modelling

2019

Bacterial infections represent an important drawback in the orthopaedic field, as they can develop either immediately after surgery procedures or after some years. Specifically, in case of implants, they are alleged to be troublesome as their elimination often compels a surgical removal of the infected implant. A possible solution strategy could involve a local coating of the implant by an antibacterial system, which requires to be easily applicable, biocompatible and able to provide the desired release kinetics for the selected antibacterial drug. Thus, this work focusses on a biphasic system made up by a thermo-reversible gel matrix (Poloxamer 407/water system) hosting a dispersed phase (…

DrugMaterials sciencemedia_common.quotation_subjectVancomycin HydrochloridePharmaceutical SciencePoloxamer02 engineering and technologyantibacterial drugengineering.material030226 pharmacology & pharmacyDiffusion03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMicro-particleCoatingVancomycinAntibacterial drugmedicineAntibacterial drugmedia_commonGelMathematical modellingReproducibility of ResultsMicro-particlesModels Theoretical021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationKineticsPLGAchemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoantibacterial drug; Gels; Mathematical modelling; Micro-particles; Orthopaedic implantsPoloxamer 407engineeringOrthopaedic implantsDelivery systemImplant0210 nano-technologyGelsmedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.

2018

Abstract Atenolol is a drug widely used for the treatment of hypertension. However, the great drawback it presents is a low bioavailability after oral administration. To obtain formulations that allow to improve the bioavailability of this drug is a challenge for the pharmaceutical technology. The objective of this work was to increase the rate and extent of intestinal absorption of atenolol as model of a low permeability drug, developing a double technology strategy. To increase atenolol permeability an ion pair with brilliant blue was designed and the sustained release achieved through encapsulation in polymeric nanoparticles (NPs). The in vitro release studies showed a pH-dependent relea…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technology030226 pharmacology & pharmacyIntestinal absorptionPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivoOral administrationmedicineAnimalsRats WistarAntihypertensive Agentsmedia_commonChromatographyChemistryBenzenesulfonates021001 nanoscience & nanotechnologyAtenololControlled releaseBioavailabilityPLGADrug LiberationAtenololIntestinal AbsorptionNanoparticles0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Carbon Nanodots as Functional Excipient to Develop Highly Stable and Smart PLGA Nanoparticles Useful in Cancer Theranostics

2020

Theranostic systems have attracted considerable attention for their multifunctional approach to cancer. Among these, carbon nanodots (CDs) emerged as luminescent nanomaterials due to their exceptional chemical properties, synthetic ease, biocompatibility, and for their photothermal and fluorescent properties useful in cancer photothermal therapy. However, premature renal excretion due to the small size of these particles limits their biomedical application. To overcome these limitations, here, hybrid poly(lactic-co-glycolic acid) (PLGA-CDs) nanoparticles with suitable size distribution and stability have been developed. CDs were decisive in the preparation of polymeric nanoparticles, not on…

Fluorescence-lifetime imaging microscopyphotothermal therapyBiocompatibilitylcsh:RS1-441Pharmaceutical ScienceExcipientNanoparticleNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesArticleNanomaterialslcsh:Pharmacy and materia medicahybrid nanoparticleschemistry.chemical_compoundcarbon nanodotmedicinecarbon nanodotsViability assaycancer theranosticChemistryhybrid nanoparticlePLGAimagingPhotothermal therapy021001 nanoscience & nanotechnology0104 chemical sciencesPLGASettore CHIM/09 - Farmaceutico Tecnologico Applicativocancer theranostics0210 nano-technologymedicine.drugPharmaceutics
researchProduct

Bioactive and biodegradable silica biomaterial for bone regeneration.

2014

Biosilica, a biocompatible, natural inorganic polymer that is formed by an enzymatic, silicatein-mediated reaction in siliceous sponges to build up their inorganic skeleton, has been shown to be morphogenetically active and to induce mineralization of human osteoblast-like cells (SaOS-2) in vitro. In the present study, we prepared beads (microspheres) by encapsulation of β-tricalcium phosphate [β-TCP], either alone (control) or supplemented with silica or silicatein, into the biodegradable copolymer poly(d,l-lactide-co-glycolide) [PLGA]. Under the conditions used, ≈5% β-TCP, ≈9% silica, and 0.32μg/mg of silicatein were entrapped into the PLGA microspheres (diameter≈800μm). Determination of …

HistologyBone RegenerationBiocompatibilityPhysiologyEndocrinology Diabetes and MetabolismBiocompatible Materials02 engineering and technologyBone healingBone tissue03 medical and health scienceschemistry.chemical_compoundCell Line TumormedicineAnimalsHumansBone regeneration030304 developmental biologyCell Proliferation0303 health sciencesInorganic polymerBiomaterialAnatomy021001 nanoscience & nanotechnologySilicon DioxideMicrospheresPLGAmedicine.anatomical_structurechemistryFemaleImplantRabbits0210 nano-technologyBiomedical engineeringBone
researchProduct

Nanoparticle formulations as recrystallization inhibitors in transdermal patches

2020

Abstract Drug crystallization in transdermal patches is still a major challenge, confronting the formulation development of topical drug delivery systems. Encapsulation of drugs into nanoparticles is proposed here as a promising tool for regulating drug crystallization in transdermal patches. The degree of recrystallization and transdermal permeation of ibuprofen and hydrocortisone loaded in polymeric and lipid nanoparticles from matrix-type transdermal patches were investigated. Ethyl cellulose (EC4), poly (lactide-co-glycolic acid) (PLGA) and polycaprolactone (PCL) were employed for polymeric nanoparticle preparations; while medium chain triglyceride (MCT) and witepsol were used for the p…

HydrocortisoneSwinePolyestersSkin AbsorptionTransdermal PatchPharmaceutical ScienceNanoparticleIbuprofen02 engineering and technology030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePolylactic Acid-Polyglycolic Acid CopolymerEthyl celluloseSolid lipid nanoparticlemedicineAnimalsCelluloseTriglyceridesSkinTransdermalDrug CarriersChemistry021001 nanoscience & nanotechnologyIbuprofenDrug LiberationPLGAChemical engineeringPolycaprolactoneNanoparticlesNanocarriersCrystallization0210 nano-technologymedicine.drugInternational Journal of Pharmaceutics
researchProduct

In vitro evaluation of poloxamer in situ forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats

2019

Graphical abstract

In situPO Propylene oxideIV IntravenousP338 Poloxamer 338lcsh:RS1-441Pharmaceutical Sciencechemistry.chemical_compoundn Sample sizeSD Standard deviationIM Intramuscularchemistry.chemical_classificationC0 Analyte plasma concentration at time zeroDoE Design of experimentsUV UltravioletPharmacology. TherapyK2.EDTA Potassium ethylenediaminetetraacetic acidLC–MS/MS Liquid chromatography-tandem mass spectrometryH&E Hematoxylin and eosintmax Sampling time to reach the maximum observed analyte plasma concentrationIn situ forming gelsCMC Critical micellar concentrationCmax Maximum observed analyte plasma concentrationIntramuscular injectionDN Dose normalizedGPT Gel point temperaturePLGA Poly-(DL-lactic-co-glycolic acid)TFA Trifluoroacetic acidCAN AcetonitrileATP Adenosine 5′ triphosphateSalt (chemistry)Polyethylene glycolPoloxamerArticlelcsh:Pharmacy and materia medicaPharmacokineticsIn vivoUHPLC Ultra-high performance liquid chromatographyPharmacokineticsAUClast Area under the analyte concentration versus time curve from time zero to the time of the last measurable (non-below quantification level) concentrationEO Ethylene oxideNMP N-methyl-2-pyrrolidoneComputingMethodologies_COMPUTERGRAPHICSAUC∞ Area under the analyte concentration vs time curve from time zero to infinite timeP407 Poloxamer 407In vitro releasePoloxamerCMT Critical micellar temperatureGel erosionIn vitrot1/2 Apparent terminal elimination half-lifechemistryMDR-TB Multi-drug resistant tuberculosisAUC80h Area under the analyte concentration versus time curve from time zero to 80 htlast Sampling time until the last measurable (non-below quantification level) analyte plasma concentrationMRM Multiple reaction monitoringNuclear chemistrySustained releaseInternational Journal of Pharmaceutics: X
researchProduct

Development of an lbuprofen-Releasing Biodegradable PLA/PGA Electrospun Scaffold for Tissue Regeneration

2009

Our aim was to develop a biodegradable fibrous dressing to act as a tissue guide for in situ wound repair while releasing Ibuprofen to reduce inflammation in wounds and reduce pain for patients on dressing changes. Dissolving the acid form of Ibuprofen (from 1% to 10% by weight) in the same solvent as 75% polylactide, 25% polyglycolide (PLGA) polymers gave uniformly loaded electrospun fibers which gave rapid release of drug within the first 8 h and then slower release over several days. Scaffolds with 10% Ibuprofen degraded within 6 days. The Ibuprofen released from these scaffolds significantly reduced the response of fibroblasts to major pro-inflammatory stimulators. Fibroblast attachment…

KeratinocytesScaffoldPolyglycolidePolyesterswound healingBioengineeringBiocompatible MaterialsIbuprofenbiodegradationApplied Microbiology and Biotechnologychemistry.chemical_compoundTissue engineeringmedicineCell AdhesionHumansdrug releaseCells CulturedCell ProliferationTissue EngineeringTissue ScaffoldsChemistryorganic chemicalsRegeneration (biology)Anti-Inflammatory Agents Non-SteroidalFibroblastsIbuprofenPLGAinflammationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDelayed-Action PreparationsLiberationWound healingPolyglycolic AcidBiotechnologyBiomedical engineeringmedicine.drug
researchProduct

Compromised integrity of excised porcine intestinal epithelium obtained from the abattoir affects the outcome of in vitro particle uptake studies

2002

Excised porcine intestinal tissue obtained from the local abattoir was studied for its suitability to examine the uptake and transport of poly(lactic-co-glycolic acid) (PLGA) nanoparticles in Peyer's (PP) and non-Peyer's patch (NPP) tissue in vitro. Incubation of such tissue with fluorescent PLGA and polystyrene particles revealed negligible uptake into the intercellular space with no noticeable difference between PP and NPP tissue. Similarly, yeast cells, which were used as a positive control for selective uptake into PP tissue, were found in the subepithelial area of both PP and NPP tissue. Therefore we examined the morphological integrity of the tissue for the duration of the experiments…

LysisCell SurvivalPolymersSwinePharmaceutical ScienceBiocompatible MaterialsSaccharomyces cerevisiaeAndrologyPeyer's Patcheschemistry.chemical_compoundPolylactic Acid-Polyglycolic Acid CopolymermedicineAnimalsLactic AcidIntestinal MucosaParticle SizeFluorescent DyesMicroscopy ConfocalTissue PreservationChemistrytechnology industry and agricultureIntestinal epitheliumSmall intestineEpitheliumIn vitroPeyer PatchPLGAmedicine.anatomical_structureMicroscopy FluorescenceBiochemistryTissue PreservationAbattoirsPolyglycolic AcidEuropean Journal of Pharmaceutical Sciences
researchProduct

?Reliability of new poly (lactic-co-glycolic acid) membranes treated with oxygen plasma plus silicon dioxide layers for pre-prosthetic guided bone re…

2017

Background: The use of cold plasmas may improve the surface roughness of poly(lactic-co-glycolic) acid (PLGA) membranes, which may stimulate the adhesion of osteogenic mediators and cells, thus accelerating the biodegradation of the barriers. Moreover, the incorporation of metallic-oxide particles to the surface of these membranes may enhance their osteoinductive capacity. Therefore, the aim of this paper was to evaluate the reliability of a new PLGA membrane after being treated with oxygen plasma (PO) plus silicon dioxide (SiO) layers for guided bone regeneration (GBR) processes. Material and Methods: Circumferential bone defects (diameter: 11 mm; depth: 3 mm) were created on the top of ei…

Malemedicine.medical_specialtyBone RegenerationSilicon dioxide02 engineering and technologyBone tissue03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePolylactic Acid-Polyglycolic Acid CopolymermedicineAnimalsLactic AcidBone regenerationGeneral DentistryGlycolic acidNanocompositeResearchoxygen plasma (PO2)technology industry and agricultureMembraneMembranes Artificial030206 dentistryAdhesionBiodegradationSilicon Dioxide021001 nanoscience & nanotechnology:CIENCIAS MÉDICAS [UNESCO]SurgeryOxygenDental ImplantationPLGASilicon dioxide layersmedicine.anatomical_structureMembraneOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASGuided Tissue Regeneration PeriodontalSurgeryRabbitsOral Surgery0210 nano-technologyPolyglycolic AcidPoly(lactic-co-glycolic acid) (PLGA)Guided bone regeneration (GBR)Biomedical engineering
researchProduct